Malignant neoplasm of pancreas
- C25 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2024 edition of ICD-10-CM C25 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C25 – other international versions of ICD-10 C25 may differ.
Use Additional
- code to identify:
- alcohol abuse and dependence (F10.-)
Code Also
- if applicable exocrine pancreatic insufficiency (K86.81)
The following code(s) above C25 contain annotation back-references
that may be applicable to C25:
Clinical Information
- A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma.
- The pancreas is a gland behind your stomach and in front of your spine. It produces juices that help break down food and hormones that help control blood sugar levels. Cancer of the pancreas is the fourth-leading cause of cancer death in the United States Some risk factors for developing pancreatic cancer include
- smoking
- long-term diabetes
- chronic pancreatitis
- certain hereditary disorders
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
Code annotations containing back-references to C25:
- Applicable To: Z85.07
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.